Skip to main content
ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
3.890
+0.080 (2.10%)
At close: Nov 13, 2026, 4:00 PM EST
3.850
-0.040 (-1.03%)
After-hours: Nov 13, 2026, 7:30 PM EST

ARS Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
122.1484.2889.150.031.325.51
Revenue Growth
-14.45%-5.46%297063.33%-97.72%-76.10%-69.13%
Gross Profit
56.0150.6768.59-20.24-15.8-14.77
Operating Income
-197.25-179.45-3.08-67.52-34.46-19.45
Net Income
-199.87-171.38-54.37-34.68-20.24
Earnings Per Share
-2.01-1.740.08-0.57-0.87-0.70
EPS Growth
------

Revenue by Geography
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
United States
97.4172.197.260.031.325.51
Rest of World
15.0312.0981.89---
Total
122.1484.2889.150.031.325.51

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
138.35244.99314.02228.36274.3860.06
Total Debt
197.02168.5169.380.270.489.03
Net Cash (Debt)
-58.6676.47244.64228.09273.951.03
Net Cash Growth
--68.74%7.26%-16.73%436.74%251.86%
Net Cash Per Share
-0.590.782.392.406.861.77

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-183.07-170.8713.55-59.27-40.08-17.56
Capital Expenditures
--0.34-0.56-0.18-0.2-0.06
Free Cash Flow
-183.07-171.2112.99-59.44-40.28-17.62
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
45.86%60.13%76.94%---268.20%
Operating Margin
-161.50%-212.92%-3.46%-225066.67%-2618.54%-353.32%
Pretax Margin
-163.71%-203.35%9.29%-181216.67%-2635.41%-367.65%
Profit Margin
-163.64%-203.25%8.97%-181216.67%-2635.41%-367.65%
FCF Margin
-149.89%-203.14%14.57%-198136.67%-3060.56%-319.94%

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--128.20---
P/FCF Ratio
--78.96---
PS Ratio
3.2013.6611.5017535.50607.80-